Sarepta Therapeutics, Inc. (BMV:SRPT)

Mexico flag Mexico · Delayed Price · Currency is MXN
368.00
+16.61 (4.73%)
Last updated: Jul 15, 2025
-85.29%
Market Cap33.59B
Revenue (ttm)45.65B
Net Income (ttm)-5.08B
Shares Outn/a
EPS (ttm)-52.93
PE Ration/a
Forward PE6.59
Dividendn/a
Ex-Dividend Daten/a
Volume6
Average Volume422
Open368.00
Previous Close351.39
Day's Range368.00 - 368.00
52-Week Range321.60 - 2,501.45
Betan/a
RSI27.23
Earnings DateAug 6, 2025

About Sarepta Therapeutics

Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat Duchenne muscular dystrophy (Duchenne) in patients with confirmed mutation of the dystrophin gene that is amenable to exon 51 skipping; VYONDYS 53 for the treatment of Duchenne in patients with confirmed mutation of the dystrophin gene that is amenable to exon 53 skipping... [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 1980
Employees 1,372
Stock Exchange Mexican Stock Exchange
Ticker Symbol SRPT
Full Company Profile

Financial Performance

Financial numbers in USD Financial Statements

News

There is no news available yet.